Arcutis Biotherapeutics ARQT
NASDAQ ARQT
$26.74 -0.59 (-2.16%)
As of: Sep 29, 2026 · 3:59 PM EDT

Arcutis Biotherapeutics (ARQT) Operating Expenses (2019 - 2026)

Updated

Arcutis Biotherapeutics' Operating Expenses was $113.43 million in Q2 2026, up 18.0% from $96.12 million a year earlier but down 0.9% from the prior quarter.

Analysis

Arcutis Biotherapeutics (ARQT) Operating Expenses (2019 - 2026) Analysis & Trends

On a trailing twelve-month basis, Arcutis Biotherapeutics' Operating Expenses was $429.73 million through Jun 30, 2026, up 23.0% year-over-year; for FY2025, it was $388.3 million, up 19.5% from FY2024.

  • Operating Expenses shows a five-year compound annual growth rate of 23.2% (FY2020 to FY2025).
  • In earlier years, Operating Expenses was $324.94 million in FY2024 (+8.1%), $300.71 million in FY2023 (-1.5%), $305.31 million in FY2022 (+47.8%) and $206.53 million in FY2021 (+51.1%).
  • Quarterly Operating Expenses has moved between $57.08 million (Q3 2021) and $114.49 million (Q1 2026) over five years.
  • Compared with a year earlier, Operating Expenses has increased for 11 straight quarters, with growth averaging 17.6% over the last eight quarters.
  • The best year-over-year quarter for Operating Expenses over five years was Q4 2021 (growth of 109.3%); the worst was Q3 2023 (a decline of 28.9%).
  • Per Business Quant data, ARQT's Operating Expenses in the three quarters before Q2 2026 was $114.49 million (Q1 2026), $111.12 million (Q4 2025) and $90.69 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 10.12 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 10.56 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 12.80 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -6.09 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -9.70 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 6.54 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 18.20 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 6.68 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 2.09 Bn
10 Arcutis Biotherapeutics 3.43 Bn 2.72 Bn 118.92 Mn 113.43 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 113.43 Mn
Mar 31, 2026 114.49 Mn
Dec 31, 2025 111.12 Mn
Sep 30, 2025 90.69 Mn
Jun 30, 2025 96.12 Mn
Mar 31, 2025 90.38 Mn
Dec 31, 2024 78.99 Mn
Sep 30, 2024 83.82 Mn
Jun 30, 2024 80.94 Mn
Mar 31, 2024 81.19 Mn
Dec 31, 2023 74.70 Mn
Sep 30, 2023 75.01 Mn
Jun 30, 2023 71.95 Mn
Mar 31, 2023 79.05 Mn
Dec 31, 2022 71.39 Mn
Sep 30, 2022 105.47 Mn
Jun 30, 2022 65.83 Mn
Mar 31, 2022 62.63 Mn
Dec 31, 2021 71.29 Mn
Sep 30, 2021 57.08 Mn
API Access

Arcutis Biotherapeutics Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=ARQT&period=max&api_key=YOUR_API_KEY